Prof. Dr. Raja Atreya

Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn's Disease (2024) Lehmann M, Weixler B, Elezkurtaj S, Loddenkemper C, Atreya I, Atreya R, Bacher P, et al. Journal article Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline (2024) Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, Germer CT, et al. Journal article PragmaticTrial Design to Compare Real-world Effectiveness of DifferentTreatments for Inflammatory Bowel Diseases:The PRACTICE-IBD European Consensus (2024) Fantini MC, Fiorino G, Colli A, Laharie D, Armuzzi A, Caprioli FA, Gisbert JP, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Real-World Global Study (2024) Atreya R, Redondo I, Streit P, Protic M, Hartz S, Gurses G, Knight H, et al. Journal article Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in Vivo (2024) Schramm S, Liu L, Saad M, Dietz L, Dedden M, Müller T, Atreya I, et al. Journal article Glowing insights: tracking vedolizumab in the mucosa of patients with IBD via molecular endoscopy (2024) Atreya R Journal article Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2) (2024) Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, et al. Journal article Unklarer Bauch: Eine therapeutische Herausforderung (2024) Atreya R Journal article